论文部分内容阅读
自1993年12月～1994年5月,我们采用口服氨基酸冲剂治疗慢性肝病患者30例。初步证实其对患者BCAA/AAA比值和改善病人蛋白质代谢等方面有良好效果,现报道如下。 1 一般资料 60例病人均为我院住院和门诊的慢性肝病患者,诊断符合1995年5月(北京)第五次全国传染病寄生虫病学术会议修定的诊断标准。采用随机配对累积病例的方法分为两组。治疗组30例,男26例,女4例,年龄21～60岁。其中慢性迁延型肝炎者2例,慢性活动型肝炎者14例,肝硬变者14例;对照组30例,男29例,女1例,年龄22～66岁。其中慢性迁延型肝炎者2例,慢性活动型肝炎者10例,肝硬变者17例,肝癌
From December 1993 to May 1994, we used oral amino acid granules to treat 30 patients with chronic liver disease. Preliminary confirmed its BCAA / AAA ratio of patients and improve patient protein metabolism and so have good results are reported below. 1 General Information 60 patients were hospitalized and outpatient patients with chronic liver disease in our hospital, diagnosis in line with the Fifth National Conference on Infectious Diseases Parasitic Diseases (Beijing) in May 1995 revised diagnostic criteria. The methods of randomly pairing cumulative cases were divided into two groups. Treatment group of 30 patients, 26 males and 4 females, aged 21 to 60 years. Among them, there were 2 cases of chronic persistent hepatitis, 14 cases of chronic active hepatitis and 14 cases of liver cirrhosis. The control group included 30 cases, 29 males and 1 females, aged from 22 to 66 years. Including chronic persistent hepatitis in 2 cases, chronic active hepatitis in 10 cases, 17 cases of liver cirrhosis, liver cancer